Meeting
2021 Genitourinary Cancers Symposium
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
Authors
İzzet Dogan
Istanbul University, Institute of Oncology, Medical Oncology, Istanbul, Turkey
İzzet Dogan , Ayca Iribas , Nail Paksoy , Meltem Ekenel , Sezai Vatansever , Mert Basaran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 289)
DOI
10.1200/JCO.2021.39.6_suppl.289
Abstract #
289
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Clinical and economic outcomes associated with sequential treatment in patients with advanced renal cell carcinoma (aRCC).
First Author: Meredith M. Regan
Poster
2018 Genitourinary Cancers Symposium
Analysis of an online tool to explore evolving practice patterns in renal cell carcinoma (RCC).
First Author: Won Kim
Poster
2022 ASCO Genitourinary Cancers Symposium
Quantifying absolute benefit of adjuvant treatments in renal cell carcinoma: A systematic review and network-meta-analysis.
First Author: Qurat Ul Ain Riaz Sipra
Poster
2022 ASCO Genitourinary Cancers Symposium
Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting.
First Author: Neil J. Shah